Journal article Open Access

DEVELOPMENT AND CHARACTERIZATION OF MICROPARTICLES OF RAZATRIPTAN BENZOATE DRUG CARRIER SYSTEM VIA NASAL ROUTE

Sunil T.Galatage1*, S.G.Killedar2, Anil Patil3, Swapnil Harale4, Y. R. Hundekar4


DCAT Export

<?xml version='1.0' encoding='utf-8'?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:adms="http://www.w3.org/ns/adms#" xmlns:cnt="http://www.w3.org/2011/content#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dct="http://purl.org/dc/terms/" xmlns:dctype="http://purl.org/dc/dcmitype/" xmlns:dcat="http://www.w3.org/ns/dcat#" xmlns:duv="http://www.w3.org/ns/duv#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:frapo="http://purl.org/cerif/frapo/" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:gsp="http://www.opengis.net/ont/geosparql#" xmlns:locn="http://www.w3.org/ns/locn#" xmlns:org="http://www.w3.org/ns/org#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:prov="http://www.w3.org/ns/prov#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:schema="http://schema.org/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:vcard="http://www.w3.org/2006/vcard/ns#" xmlns:wdrs="http://www.w3.org/2007/05/powder-s#">
  <rdf:Description rdf:about="https://doi.org/10.5281/zenodo.2583574">
    <rdf:type rdf:resource="http://www.w3.org/ns/dcat#Dataset"/>
    <dct:type rdf:resource="http://purl.org/dc/dcmitype/Text"/>
    <dct:identifier rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://doi.org/10.5281/zenodo.2583574</dct:identifier>
    <foaf:page rdf:resource="https://doi.org/10.5281/zenodo.2583574"/>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Sunil T.Galatage1*, S.G.Killedar2, Anil Patil3, Swapnil Harale4, Y. R. Hundekar4</foaf:name>
        <foaf:givenName>S.G.Killedar2, Anil Patil3, Swapnil Harale4, Y. R. Hundekar4</foaf:givenName>
        <foaf:familyName>Sunil T.Galatage1*</foaf:familyName>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>1* Sant Gajanan Maharaj College of Pharmacy Mahagaon, Tal-Gadahinglaj, Dist-Kolhapur-416502, Maharashtra. 2BVCP College of Pharmacy Kolhapur 3KLE College of Pharmacy Nippani. 4Sant Gajanan Maharaj College of Pharmacy Mahagaon, Tal-Gadahinglaj, Dist-Kolhapur-416502, Maharashtra.</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:title>DEVELOPMENT AND CHARACTERIZATION OF MICROPARTICLES OF RAZATRIPTAN BENZOATE DRUG CARRIER SYSTEM VIA NASAL ROUTE</dct:title>
    <dct:publisher>
      <foaf:Agent>
        <foaf:name>Zenodo</foaf:name>
      </foaf:Agent>
    </dct:publisher>
    <dct:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#gYear">2019</dct:issued>
    <dcat:keyword>Intra Nasal Mucoadhesive Microparticle, Rizatriptan Benzoate, Mucoadhesion Time, In-Vitro Drug Release Etc.</dcat:keyword>
    <dct:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2019-03-05</dct:issued>
    <owl:sameAs rdf:resource="https://zenodo.org/record/2583574"/>
    <adms:identifier>
      <adms:Identifier>
        <skos:notation rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://zenodo.org/record/2583574</skos:notation>
      </adms:Identifier>
    </adms:identifier>
    <dct:isVersionOf rdf:resource="https://doi.org/10.5281/zenodo.2583573"/>
    <dct:isPartOf rdf:resource="https://zenodo.org/communities/iajpr"/>
    <dct:description>&lt;p&gt;Objective: Rizatriptan Benzoate is the 5H1 receptor agonist and used in treatment of migraine, cluster headache. The main objective is to develop ideal anti-migraine nasal mucoadhesive microparticles as local and systemic drug delivery system. Method: An attempt was made to formulate the nasal mucoadhesive microparticle of Rizatriptan Benzoate with excipients like mucoadhesive polymers i.e HPMC, ethyl cellulose etc., by using modified solvent evaporation method. And evaluated them for production yield, drug loading efficiency, surface morphology by SEM, drug content, particle size, &lt;em&gt;In-vitro&lt;/em&gt; drug release studies. The release rates were studied using GRAPHPAD PRISM software. Result and discussion: The prepared microparticles of Rizatriptan Benzoateformulations were found to be satisfactory particle size i.e in the range of 36.96 to 53.28&amp;micro;m,mucoadhesion time of&amp;nbsp; F5 found to be 370 min,drug content was found to be72.86 % to 81.80 % and drug release of the drug follow zero order kinetic model. Optimized formulation F5shows that the developed formulations have shown improved dissolution profile in comparison to other formulation.The developed nasal mucoadhesive microparticles are having potential to deliver of anti-migraine drugs via nasal route.&lt;/p&gt;</dct:description>
    <dct:accessRights rdf:resource="http://publications.europa.eu/resource/authority/access-right/PUBLIC"/>
    <dct:accessRights>
      <dct:RightsStatement rdf:about="info:eu-repo/semantics/openAccess">
        <rdfs:label>Open Access</rdfs:label>
      </dct:RightsStatement>
    </dct:accessRights>
    <dcat:distribution>
      <dcat:Distribution>
        <dct:license rdf:resource="http://creativecommons.org/licenses/by/4.0/legalcode"/>
        <dcat:accessURL rdf:resource="https://doi.org/10.5281/zenodo.2583574"/>
      </dcat:Distribution>
    </dcat:distribution>
  </rdf:Description>
</rdf:RDF>
23
12
views
downloads
All versions This version
Views 2323
Downloads 1212
Data volume 12.8 MB12.8 MB
Unique views 2323
Unique downloads 1212

Share

Cite as